Journal article
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
M Lemoine, Y Shimakawa, R Njie, M Taal, G Ndow, I Chemin, S Ghosh, HF Njai, A Jeng, A Sow, C Toure-Kane, S Mboup, P Suso, S Tamba, A Jatta, L Sarr, A Kambi, W Stanger, S Nayagam, J Howell Show all
Lancet Global Health | ELSEVIER SCI LTD | Published : 2016
Abstract
Background Despite the introduction of immunisation for hepatitis B virus (HBV) in the 1990s, HBV-related morbidity and mortality remain high in sub-Saharan Africa. Identification and treatment of asymptomatic people with chronic HBV infection should reduce the disease burden. We therefore assessed the feasibility of a screen-and-treat programme for HBV infection in The Gambia, west Africa, and estimated the proportion of HBV-infected people who had significant liver disease in need of treatment. Methods Between Dec 7, 2011, and Jan 24, 2014, individuals living in randomly selected communities in western Gambia were offered hepatitis B surface antigen (HBsAg) screening via a point-of-care te..
View full abstractGrants
Awarded by Agence Nationale de la Recherche
Funding Acknowledgements
European Commission (FP7).